Gene: RAB5A
Official Full Name: RAB5A, member RAS oncogene familyprovided by HGNC
Gene Summary: Enables GDP binding activity; GTP binding activity; and GTPase activity. Involved in several processes, including amyloid-beta clearance by transcytosis; early endosome to late endosome transport; and regulation of exocytosis. Located in several cellular components, including cytoplasmic side of early endosome membrane; nucleoplasm; and terminal bouton. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08838 | RAB5A Knockout cell line (HeLa) | Human | RAB5A | 1:3~1:6 | Negative | Online Inquiry |
KO08839 | RAB5A Knockout cell line (HCT 116) | Human | RAB5A | 1:2~1:4 | Negative | Online Inquiry |
KO08840 | RAB5A Knockout cell line (HEK293) | Human | RAB5A | 1:3~1:6 | Negative | Online Inquiry |
KO08841 | RAB5A Knockout cell line (A549) | Human | RAB5A | 1:3~1:4 | Negative | Online Inquiry |
RAB5A Gene Knockout Cell Lines are genetically engineered model systems designed to study the functional role of the RAB5A gene, a key regulator in endocytic vesicle trafficking. By utilizing CRISPR/Cas9 gene editing technology, these cell lines facilitate the complete ablation of RAB5A expression, allowing researchers to investigate its impact on cellular processes such as membrane trafficking, receptor signaling, and autophagy.
The primary function of RAB5A is to mediate early endosomal dynamics, thereby critically influencing the trafficking and sorting of proteins and lipids within the cell. By employing RAB5A knockout cell lines, scientists can elucidate the downstream effects of disrupted endosomal pathways, providing insights into various diseases characterized by trafficking anomalies, such as neurodegenerative disorders and cancer.
The scientific significance of RAB5A Gene Knockout Cell Lines extends beyond basic research; these cell lines are invaluable in clinical contexts, particularly in drug discovery and development. They enable researchers to identify potential therapeutic targets by providing a controlled environment to assess how the loss of RAB5A alters cellular responses to treatments or pathological stimuli. Moreover, these knockout cell lines can serve as a valuable tool for high-throughput screening of compounds that can rescue or exacerbate the phenotypic consequences of RAB5A dysfunction.
What sets RAB5A Gene Knockout Cell Lines apart from alternative models is their precise gene deletion, which allows for a comprehensive assessment of specific gene functions without the confounding effects of partial expression. Additionally, the reproducibility of CRISPR/Cas9 technology ensures that these cell lines maintain consistency across experiments, enhancing the reliability of derived data.
For researchers and clinicians seeking unequivocal insights into endocytic mechanisms and therapeutic interventions, RAB5A Gene Knockout Cell Lines provide a robust experimental framework. Our company specializes in developing cutting-edge biological tools, ensuring that our products reflect the highest standards of genetic engineering and biological research to empower scientists in their quest to uncover novel solutions to pressing biomedical challenges.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.